Monika Ermann
Evotec (Germany)(DE)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Chemical Synthesis and Analysis, Synthesis and Biological Evaluation, Neurotransmitter Receptor Influence on Behavior, Multicomponent Synthesis of Heterocycles
Most-Cited Works
- → Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies(2015)124 cited
- → Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity(2008)63 cited
- → Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and in Vivo Antiinflammatory Activity(2006)61 cited
- → Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity(2008)30 cited
- → Some regioselective cross-coupling reactions of halopyridines and halopyrimidines(2002)26 cited
- → 1,4-Diazepane compounds as potent and selective CB2 agonists: Optimization of metabolic stability(2011)21 cited
- → Selective CB2 receptor agonists. Part 1: The identification of novel ligands through computer-aided drug design (CADD) approaches(2014)21 cited
- → Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: Optimization of drug-like properties and target independent parameters(2011)14 cited
- → Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effects(2022)14 cited
- → Selective CB2 receptor agonists. Part 2: Structure–activity relationship studies and optimization of proline-based compounds(2014)14 cited